Company Quick10K Filing
Belmond
10-K 2018-12-31 Filed 2019-02-28
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-03-01
10-Q 2017-09-30 Filed 2017-11-07
10-Q 2017-06-30 Filed 2017-08-08
10-Q 2017-03-31 Filed 2017-05-09
10-K 2016-12-31 Filed 2017-02-28
10-Q 2016-09-30 Filed 2016-11-03
10-Q 2016-06-30 Filed 2016-08-04
10-Q 2016-03-31 Filed 2016-05-05
10-K 2015-12-31 Filed 2016-02-25
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-07-31
10-Q 2015-03-31 Filed 2015-05-01
10-K 2014-12-31 Filed 2015-02-27
10-Q 2014-09-30 Filed 2014-11-06
10-Q 2014-06-30 Filed 2014-08-01
10-Q 2014-03-31 Filed 2014-05-02
10-K 2013-12-31 Filed 2014-02-28
10-Q 2013-09-30 Filed 2013-11-01
10-Q 2013-06-30 Filed 2013-08-01
10-Q 2013-03-31 Filed 2013-05-03
10-K 2012-12-31 Filed 2013-02-26
10-Q 2012-09-30 Filed 2012-11-05
10-Q 2012-06-30 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-09
10-K 2011-12-31 Filed 2012-02-29
10-Q 2011-09-30 Filed 2011-11-08
10-Q 2011-06-30 Filed 2011-08-08
10-Q 2011-03-31 Filed 2011-05-09
10-K 2010-12-31 Filed 2011-02-25
10-Q 2010-09-30 Filed 2010-11-05
10-Q 2010-06-30 Filed 2010-08-06
10-Q 2010-03-31 Filed 2010-05-07
10-K 2009-12-31 Filed 2010-02-26
8-K 2019-04-17
8-K 2019-02-27
8-K 2019-02-14
8-K 2019-01-08
8-K 2018-12-13
8-K 2018-11-06
8-K 2018-10-11
8-K 2018-08-24
8-K 2018-08-08
8-K 2018-08-08
8-K 2018-07-06
8-K 2018-06-01
8-K 2018-05-08
8-K 2018-04-20
8-K 2018-04-03
8-K 2018-02-26
8-K 2018-02-08

Belmond Financials

BEL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
Bioquest Corp (BQST)
11 Good Energy (ELVN)
BriaCell Therapeutics Corp. (BCTXW)
1347 Capital Corp (TFSC)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Ameren Illinois Co (AILNP)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
SERA PROGNOSTICS, INC. (SERA)
Xiaoju Kuaizhi Inc. (DIDI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
COMSovereign Holding Corp. (COMSW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-31
Cash1131321501171131199067721029379114153123134133159135110157175136121145178153131114205180142169150112
Accounts Receivable6160514351464551514737404344353641393032353327293132262937433451615438
Inventory4245444650474446444545434545454544413128282626272727242425242322222221
PP&E1,2421,2861,2691,2841,6071,5071,4631,5181,4051,4451,4731,4301,4391,4771,4521,4001,4261,5741,5071,4341,4761,4361,4221,4651,4651,4811,4441,4761,5731,5881,5861,6811,6621,6761,702
Assets2,1232,1712,1382,1702,1692,0061,9311,9481,8991,9141,8921,8241,8601,9191,8801,8201,8331,7801,6681,5851,6161,5901,5091,5311,5461,5881,5241,5281,6131,7181,6541,7051,7271,7221,676
Accounts Payable2929252240312927292825232723242126252517232016131517161319161616182623
Long-Term Debt535241511522612572544537525517522424438351473546541621612591596595578584595596586587597698701746778740754
Liabilities1,1551,1931,0651,0891,0801,0169789909719689549479719989699799759629068849039088518608758908378449159959551,0071,0591,0471,036
Stockholders' Equity9659761,0711,0791,087988950955926943936875886918908840856817761701712681658670670698686684697723699698668674640
Income Statement ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-31
Revenue169182128104177184124109162160121104172187131103176184124991611681239715418411495166183490172193
Cost of Revenue
Gross Profit
R&D
SG&A50494849606057535551545562585751585754485554494750534852745954566968
Tax6710-5954867106412941215-151611-151420-9422192714
Net Income-1-22-26-155-50-28-151218-21-471716-18-21615-2-91590-18237-18-58-30-15-213
Cash Flow ($MM)2010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-31
Cash Operating39-21-13128-13-72646-19-63852-16-113043-10-13943-12-22248-6-92152-13-73365
Cash Investing-6-12-239-11-9-2456-2-22-14-627-27-11-10-1724-10-14-11-14-13-15-12-84-15-9-76-45-43
Cash Financing-1351-10-45-17-20-74-14-2-419-1-6-4-50-2-1-19-12-11-316-1-1-24449-13844-39